HSV-2 IgG Positive: Interpretation and Management
A positive HSV-2 IgG result indicates past or current HSV-2 infection, but the clinical significance depends entirely on whether you have genital symptoms—if symptomatic, offer suppressive therapy; if asymptomatic, counsel about transmission risk but treatment is generally not indicated unless the patient has a known HSV-2 positive partner or desires to reduce transmission risk. 1
Understanding the Test Result
Test Performance Limitations
- Commercial HSV-2 IgG assays have important limitations that affect interpretation. The Roche and Bio-Rad assays demonstrate high sensitivity (>97%) and specificity (>98%) for HSV-2 IgG detection, while the DiaSorin assay has concerning false positive rates—nearly one in three positive DiaSorin results may be falsely positive in the general population 2
- Low-positive index values (1.10-3.50) require confirmatory testing, as 20-39% of false-positive results occur even above the traditional 3.50 cutoff depending on the assay used 3, 4
- If your result shows a low-positive index value, request confirmatory testing with an inhibition assay or alternative platform before making clinical decisions 3
Clinical Correlation with Symptoms
- Symptom history does NOT reliably predict HSV-2 antibody positivity. Studies show no significant association between genital herpes symptom history and HSV-2 seropositivity—31% of asymptomatic individuals tested positive compared to 50% with multiple prior symptoms 5
- Approximately 20% of HSV-2 seropositive persons never recognize genital symptoms consistent with herpes 1
When HSV-2 Serology Is Indicated
The USPSTF recommends AGAINST routine screening in asymptomatic individuals 1. However, testing is appropriate for:
- Persons with current or past genital symptoms (classic vesicular lesions or atypical symptoms like recurrent fissures, irritation, or dysuria) to establish diagnosis 1
- Sexual partners of known HSV-2 positive individuals to guide counseling about transmission risk 1
- Individuals previously told they have genital herpes without virologic confirmation 1
- Screening is NOT recommended for asymptomatic pregnant women 1
Management Based on Symptom Status
Symptomatic HSV-2 Infection
All symptomatic patients should be offered suppressive therapy (daily antiviral medication), though episodic therapy (treatment only during outbreaks) is also an option 1:
- Suppressive therapy benefits include: reducing recurrence frequency, improving quality of life, and preventing transmission to sexual partners through suppression of viral shedding 1
- FDA-approved antivirals include acyclovir, famciclovir, and valacyclovir—choose regimens with less frequent dosing to optimize adherence 1
- Suppressive therapy prevents transmission in heterosexual couples, MSM, women who have sex with women, and transgender persons, but is NOT effective in HIV/HSV-2 coinfected individuals 1
Asymptomatic HSV-2 Infection
- Antiviral treatment is generally not indicated for asymptomatic infection unless the patient specifically desires to reduce transmission risk to partners 1
- Provide counseling about transmission risk, including that viral shedding occurs even without symptoms
- Discuss that suppressive therapy can reduce (but not eliminate) transmission risk if the patient has concerns about infecting partners 1
Common Pitfalls to Avoid
- Do not rely on symptom history alone to determine who needs testing—many infected individuals are asymptomatic or don't recognize symptoms 5
- Do not accept low-positive results without confirmation, especially with DiaSorin assays where false positivity rates are substantial 2, 3
- Do not assume HSV-1 serology is useful for genital herpes diagnosis—HSV-1 IgG has poor specificity and sensitivity for diagnosing genital disease due to high oropharyngeal HSV-1 seroprevalence 6
- HSV-2 IgG serology cannot distinguish between oral and genital infection, though HSV-2 is predominantly genital (>90% of cases) 1